Company intelligence / Profile preview

Covance

Princeton, New Jersey, United Statescovance.com ↗

Ownership: Private
Employees: ~26000
Development stage: Other

Overview

Covance (now Labcorp Drug Development) is a leading global CRO that provided comprehensive nonclinical and clinical development services, contributing to the success of most top prescription drugs, but does not itself advance a proprietary clinical pipeline.

Therapeutic areas: Other
Modalities: Small moleculeBiologicMonoclonal antibodyCell and gene therapy
Industry: Contract Research Organization

Partnerships

Major pharmaceutical, biotech, and medical device companies

Beyond the preview

Go deeper on Covance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Covance.

Explore the full profile